Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;20(5):559-564.
doi: 10.1111/ajco.13908. Epub 2023 Mar 13.

Incidence and risk factors for neoplasia in inflammatory bowel disease

Joana Lemos Garcia  1 , Isadora Rosa  1 , João Pereira da Silva  1 , Joana Moleiro  1 , Isabel Claro  1
Affiliations

Incidence and risk factors for neoplasia in inflammatory bowel disease

Joana Lemos Garcia et al. Asia Pac J Clin Oncol. 2024 Oct.

Abstract

Introduction: Inflammatory Bowel Disease (IBD) patients may have an increased risk of neoplasia. The aim was to evaluate the incidence of malignant neoplasia in IBD patients, associated risk factors and therapy adjustments.

Methods: Unicentric retrospective cohort study. All patients followed for IBD in a tertiary portuguese hospital and oncological centre during 2015-2020 were included.

Results: 318 patients were included female 55.0%, age at diagnosis = 37.24(±15,28), Crohn's disease 52.5%, Primary Sclerosing Cholangitis n = 7, family history of cancer n = 12, previous diagnosis of neoplasia n = 23(7.2%). 42 cancers were diagnosed in 35 patients (11.0%) - median of 12.0(IQR = 7.5-21.0) years after IBD diagnosis. Most affected organs were the skin (n = 15 in 11 patients; melanoma = 1), colon/rectum (n = 8 in 6 patients), prostate (n = 4), breast (n = 3) and anal canal (n = 2). In those with non-melanoma skin cancer, 6 were under active treatment with azathioprine and 2 had stopped it for more than two years. In the univariate analysis, the occurrence of neoplasia was positively associated with tobacco exposure (p = 0.022), age at IBD diagnosis (p = 0.021), and negatively with infliximab exposure (p = 0.046). In 9 cases, cancer treatment was different because of the IBD, while IBD treatment was changed in 9 patients. In those affected by cancer, in the univariate analysis, its cure/remission was negatively associated with tobacco exposure (p = 0.004) and positively with salicylates use (p = 0.007).

Conclusion: In IBD patients, cancer mostly affected the skin and the lower digestive system. As in the general population, tobacco exposure was a risk factor for the development of neoplasia.

Keywords: cancer; crohn's disease; inflammatory bowel disease; neoplasia; ulcerative colitis.

PubMed Disclaimer

References

REFERENCES

    1. Borren NZ, Ananthakrishnan AN. Safety of Biologic Therapy in Older Patients with Immune‐ Mediated Diseases: A Systematic Review and Meta‐Analysis. Clin Gastroenterol Hepatol. 2019;17(9):1736–43.
    1. Piovani D, Danese S, Peyrin‐Biroulet L, Nikolopoulos GK, Bonovas S. Systematic review with meta‐analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020;51(9):820–30.
    1. Wilson JC, Furlano RI, Jick SS, Meier CR. A population‐based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease. J Gastroenterol. 2016;51(11):1050–62.
    1. Waljee AK, Higgins PDR, Jensen CB, et al. Anti‐tumour necrosis factor‐α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population‐based cohort study. The Lancet Gastroenterology and Hepatology. 2020;5(3):276–84.
    1. Taborelli M, Sozzi M, Del Zotto S, et al. Risk of intestinal and extra‐intestinal cancers in patients with inflammatory bowel diseases: A population‐based cohort study in northeastern Italy. PLoS One. 2020;15(6):1–14.